David Caudell to Tumor Burden
This is a "connection" page, showing publications David Caudell has written about Tumor Burden.
Connection Strength
0.037
-
Alexander PM, Caudell DL, Kucera GL, Pladna KM, Pardee TS. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia. PLoS One. 2017; 12(6):e0179798.
Score: 0.037